A Proteomics Signature of NASH - Non-Invasive Assessment of Nonalcoholic Fatty Liver Disease
Offered By: Labroots via YouTube
Course Description
Overview
Explore the latest advancements in proteomics for diagnosing and monitoring nonalcoholic steatohepatitis (NASH) in this comprehensive webinar presented by Dr. Arun Sanyal. Delve into the global prevalence of nonalcoholic fatty liver disease (NAFLD) and the urgent need for non-invasive diagnostic tools. Learn about the development and validation of proteomics-based models for assessing key liver biopsy components and at-risk NASH. Discover how these innovative "liquid biopsy" techniques could revolutionize NAFLD assessment, potentially replacing invasive liver biopsies. Gain insights into ongoing clinical trials, disease progression, and effective strategies for managing NASH. Engage with cutting-edge research on serum protein profiling and its implications for diagnosis, prognosis, and monitoring of NAFLD and NASH.
Syllabus
Introduction
Liver Journey
Effective Strategies
Collaborative Project
Data Summary
Disease Progression
Pivence Trial
Flint Study
Clinical Trials
Summary
Live QA
Taught by
Labroots
Related Courses
Facts About Scleroderma - A Rheumatologist ExplainsConnected Rheumatology via YouTube Restrictive Cardiomyopathy - Causes, Symptoms, Diagnosis & Treatment - Cardiology Series
Medicosis Perfectionalis via YouTube Musculoskeletal Manifestations in Systemic Sclerosis
National Scleroderma Foundation via YouTube Scleroderma Research Progress: 25 Years of Advancements and Future Prospects - 2023 Closing Keynote
National Scleroderma Foundation via YouTube Updates in Juvenile Localized Scleroderma
National Scleroderma Foundation via YouTube